🇺🇸 FDA
Company

Dyne

Dyne Therapeutics

DYN pharma USA

Quick answer

Dyne is a pharma company (DYN) headquartered in WALTHAM, MA, USA with 3 tracked pipeline programs.

Pipeline (3)

project

zeleciment basivarsen (DYNE-101)

Myotonic Dystrophy Type 1 (DM1)

Phase 3 · small_molecule · active

1 trials project

DYNE-101

Myotonic Dystrophy Type 1 (DM1)

Phase 2 · small_molecule · active

1 trials project

DYNE-251

Duchenne Muscular Dystrophy (DMD)

Phase 2 · small_molecule · active

1 trials

Drugs (1)

drug

propoxyphene napsylate

DARVON-N

Patents (8)

patent

US 12428487

Complexes comprising an anti-transferrin receptor antibody linked to an oligonic

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12403203

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12397062

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12370264

Complexes comprising an anti-transferrin receptor antibody linked to an oligonuc

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12357703

Muscle-targeting complexes comprising an anti-transferin receptor antibody linke

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12329824

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12329825

Muscle targeting complexes comprising an anti-transferrin receptor antibody link

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12325753

Method of using an anti-transferrin receptor antibody to deliver an oligonucleot

Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)